Acuta Capital Partners, LLC Vericel Corp Put Options Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
289Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$461 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$200 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$185 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$138 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$128 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.7B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...